Physician profile
Kelsey Oakleaf
NPI 1922672104
$2,848.14
in general payments reported to CMS, 2019-2025
23 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $656 · 2022: $1,073 · 2023: $582 · 2024: $166 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $427.59 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $317.64 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $309.15 | 2022-2025 | |
| Amgen INC. | $176.06 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $170.46 | 2022-2024 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $155.07 | 2022-2023 | Camzyos |
| Revance Therapeutics, INC. | $147.73 | 2025 | Daxi |
| Nuwellis, INC. | $142.87 | 2021 | |
| Novo Nordisk INC | $134.13 | 2021-2022 | |
| Cvrx, INC. | $131.45 | 2022-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $114.09 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.23 | 2022-2025 | Lifevest |
| Esperion Therapeutics, INC. | $100.08 | 2021-2024 | Nexletol |
| Kestra Medical Technology Services, INC. | $96.12 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $82.50 | 2022-2023 | Arcalyst |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.72 | 2022-2023 | Jardiance |
| Abiomed | $32.18 | 2025 | |
| Amarin Pharma, INC. | $31.67 | 2022 | |
| Boston Scientific Corporation | $23.71 | 2025 | Varithena Administration Pack |
| Lexicon Pharmaceuticals, INC. | $21.23 | 2023 | Inpefa |
| Medtronic, INC. | $20.13 | 2024 | Mycarelink |
| Bayer Healthcare Pharmaceuticals INC. | $18.45 | 2021 | |
| Daiichi Sankyo INC. | $13.88 | 2023 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Oakleaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.